Dabur Research Foundation Information 

Preclinical services in Drug Discovery and Development are provided by Dabur Research Foundation (DRF), an Indian Contract Research Organisation founded in 1979. These services include the discovery of prospective lead compounds, DRF drug development, and IND enabling studies. We provide preclinical services to the biotech, Althea pharmaceuticals, phytopharmaceutical, cosmetics, and academic industries on a global scale. Our offerings mostly fall under the functional categories of DMPK, Exploratory & GLP Toxicology, In Vivo and in Vitro Pharmacology. Our origins are with the Dabur group of enterprises, and in 2008, following a strategic spin-off from our parent firm, we began doing business as a preclinical service provider. We as a preclinical service provider provide our clients the benefit of our thirty years of drug discovery and development knowledge.

HISTORY

•  Established in 1979 to lead Dabur's R&D initiatives

•  With a market capitalization of $12 billion USD, the Dabur Group of Companies is one of India's leading healthcare providers.

• Dabur Research Foundation, a firm centered on natural products that was founded roughly 135 years ago, now employs over 7000 people across more than 50 nations.

• One of Dabur's subsidiaries, Dabur Oncology, rose to become the region's leading provider of cancer treatment.

• DRF separated from its parent business in 2008 to establish itself as a CRO for preclinical research.

• One of the top preclinical research facilities, DRF has a space of about 75000 square feet.

• Modern, 30,000 square foot, OECD GLP/AAALAC compliant small animal facilities are available at DRF UK.

OUR TRAVELS

• Founded by a group of successful businesspeople and scientists who specialize in drug discovery. extensive knowledge and expertise in botanical and synthetic lead translational research.

• Providing clinical services & product development solutions for pharmaceutical & phytopharmaceutical products to our partners.

• 20+ years providing complete services to support global registration requirements for health and wellness, pharmaceuticals, biotechnology, nutraceuticals, and agrochemicals.

• AAALAC and OECD GLP compliant.

• 100+ scientists were hired from India's top 5 universities; the PhD to Master's ratio was 1:2.

• Preclinical research management experience spanning more than 100 years.

• Effective operation is guaranteed by the institution's biosafety committee, animal ethics committee, and occupational health and safety committee.

Mission

Dabur research organization –

• •  To be a premier Preclinical Contract Research Organization in India via superior leadership, services, and collaborations in the pharmaceutical industry. 

  • Becoming the top-choice preclinical contract research organization in India by providing complete services & creative solutions throughout the development value chain.

  • To provide our clients with the India edge while keeping the highest possible level of services offered.

  • To fulfil our social responsibility by utilizing our services and collaborations to hasten medication research and development across a variety of therapeutic areas.

Vision

Becoming the most reputable and successful preclinical contract research company in India while adding value for its clients and stakeholders.

Drug Discovery & Development Services

With an Althea wealth of knowledge in DMPK, exploratory & GLP toxicology, in vivo and in vitro pharmacology.